Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Ixempra (Ixapebilone) chemotherapeutic agent – New Cancer Therapy

Drug (Brand/Generic)

Ixempra/Ixabepilone

Company/Licensee

BMS

Therapy Class

Epothilone

Product Description

Microtubule inhibitor

Current Indication

Metastatic or locally advanced breast cancer

Market Sector

Oncology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top